Our Innovation
Innovation That Transforms Oncology
At KeyZell Biotech, innovation is at the core of our mission. Our approach combines advanced biotechnology with deep scientific expertise to not only treat cancer but redefine oncology care standards.
From developing the drug LZ-167 to pioneering diagnostic and precision medicine platforms, we aim to revolutionize how cancer is approached—focusing on precision, effectiveness, and improving patients’ quality of life.
Our Innovative Solutions
LZ-167: A New Hope in Oncology
Breakthrough Therapeutic Target
LZ-167 employs a targeted approach, acting on tumor cells while preserving healthy ones, reducing side effects from traditional treatments.
Multidimensional Action
No solo inhibe el crecimiento tumoral, sino que regula el microambiente para evitar la progresión del cáncer.
Current Status
Preparing for clinical trials in 2025, with the goal of establishing LZ-167 as a first-line treatment for multiple cancer types.
Focus on Precision Medicine
Our vision for oncology goes beyond treatment—it includes personalizing every medical decision:
Molecular and Genetic Analysis
Using biomarkers and genetic data to tailor therapies to each patient's unique characteristics.
Recurrence Prevention
Predictive tools that anticipate relapses and optimize interventions proactively.
Artificial Intelligence Platforms
KeyZell also leads in developing technology-driven solutions for oncology through our advanced platforms:
O.P.S. (Oncology Precision System)
• A Machine Learning-based tool that recommends personalized treatments with 89% accuracy.
• Reduces side effects and improves 5-year survival rates.
O.D.S. (Oncology Diagnostic System)
• A Deep Learning platform that diagnoses cancer via imaging with 93% accuracy in seconds.
• Enables early detection, crucial for effective treatment.
The Impact of Our Innovation
On Medicine
• Personalized Treatments: Higher efficacy and lower toxicity.
• Early Diagnosis: Improved survival rates through earlier detection.
On a Global Scale
• Scalable Accessibility: Solutions designed to be implemented across diverse clinical settings, from specialized hospitals to public health systems.
• Cost Efficiency: Optimized resources through advanced technology and targeted treatments.
On Humanity
• Quality of Life: Patients Benefit from les invasive, more effective therapies.
• Empowering Healthcare Providers: Tools that enable faster and more informed decision-making for clinicians.
Innovation Through Collaboration
Our ability to innovate is supported by:
Strategic Collaborations
With leading hospitals and research centers in Spain, Mexico, and Australia.
International Validations
Recognition of our platforms by ethical committees and their integration into healthcare systems.
Join Our Revolution in Oncology
Whether you are a medical professional, investor, or research center, your ideas and collaboration can help further our mission.
